The product will be manufactured at subsidiary Aurolife Pharma’s Raleigh facility in North Carolina and expected to be launched in upcoming quarters.
Back to Business
Business
September 15, 2026 at 3:08 PM
Aurobindo Pharma wins U.S. FDA approval for generic asthma inhaler
The Hindu Business